We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Inspiration Healthcare Group Plc | LSE:IHC | London | Ordinary Share | GB00BXDZL105 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 13.75 | 13.50 | 14.00 | 13.75 | 13.75 | 13.75 | 36,407 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Home Health Care Services | 37.63M | -6.03M | -0.0673 | -2.04 | 12.33M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/9/2020 06:29 | So, Cenkos note just out, with an intention to update next month! It does state £7m revenue and £1m EBIDTA not currently included in existing forecasts. | hastings | |
16/9/2020 06:17 | Echo that rivaldo, perhaps we will now get the upgrade I've been expecting! | hastings | |
16/9/2020 06:13 | Great to see the NHS ventilator deliveries increasing to a total £7.1m. IHC will continue to benefit from ongoing ventilator support contract orders. And there's the closing sentence that "The additional revenues from these orders positions the Company very well to achieve a strong performance this financial year." | rivaldo | |
02/9/2020 15:56 | I see this breaking out higher..... free stock charts from uk.advfn.com | troutisout | |
20/8/2020 06:31 | Excellent news: - strong trading continues into H2 - the original NHS order deliveries will further benefit H2 - the second NHS order via the newly acquired SLE is a further bonus I was unaware of? - further optimism as to the outlook and to acquisition integration | rivaldo | |
20/8/2020 06:10 | Update on Ventilator Delivery to the NHS Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company is pleased to provide a further update on the status for the delivery of ventilators as the UK National Health Service demand for Covid ventilators likely diminishes, the Group continues to satisfy the orders received from the UK National Health Service announced on the 16th and 20thMarch 2020 with a value totalling approximately £5 million. In the last few days the Company delivered a further £1million of the orders, taking the total amount delivered under these contracts to £3 million. On the 11th August 2020, the Company gave an update on trading stating that underlying revenues (ie prior to any contribution from S.L.E. or Covid opportunities) for the Group in the first six months were running 30% ahead of last year, with a healthy order book in place. This strong performance continues and, in addition, the recently acquired S.L.E. has, in the last few days, also delivered over £0.5 million of ventilators to the NHS as part of a separate order they had received. The integration of S.L.E. into the Group is progressing according to plan and is providing the significant short and long term commercial synergies expected by management. Neil Campbell, Chief Executive Officer, commented, "We have continued to work tirelessly with our partners to get the ventilators into the UK and delivered to the NHS. At the same time, I'm pleased to report that the Company is trading well across all its operations and we are working well with our colleagues at S.L.E. to integrate the two businesses and also at Viomedex, which means that we remain optimistic of our continued progress for this financial year and beyond." | valustar1 | |
17/8/2020 09:26 | IHC reposted a tweet from 3 months ago on their Twitter feed last week, the tweet linked to this article below, with the 10m backlog for operations and the restart to elective surgeries, the demand can only continue to soar..... | troutisout | |
12/8/2020 11:14 | Cheers - very positive. If they're already confident enough at this early stage to state that they'll meet expectations for the year, then a little more good news may well be enough to trigger an "ahead of expectations" statement. | rivaldo | |
12/8/2020 10:32 | Interview with CEO here, all sounding very positive, the 30% rise was LFL and doesn't include the NHS ventilator contracts of which £2m have been delivered in H1 with £3m to follow. | troutisout | |
12/8/2020 09:46 | Looks like they may be some buy orders in, were the 63.6p trades sells, I certainly was quoted that for a sell soon after? | troutisout | |
12/8/2020 08:05 | I guess you've got direct market access then? Lowest I was quoted was 60.26p | lammylover | |
12/8/2020 07:18 | I got a nice little batch (or was it a tranche?) at 59.6p | thamestrader | |
11/8/2020 15:22 | was prob panic sellingi was able to pick some up at 60 | scepticalinvestor | |
11/8/2020 15:00 | Agreed Rivaldo. Can't believe people gave away their shares at 58p this morning. Daft. | lammylover | |
11/8/2020 14:47 | Bouncing now as the results and prospects sink in..... | rivaldo | |
11/8/2020 08:27 | It's just lots of people don't know what market expectations actually are.... Cenkos forecast revenues of £28.1m for this year against an actual revenue for last year of £17.8m, this includes 6 months from SLE, the note before the acquisition of SLE forecast revenues of £20.5m for this year. Either way market expectations are a good deal higher than last year, so to believe they will hit those expectations so early in H2 must be a positive and leaves some upside as trading in H2 continues... | troutisout | |
11/8/2020 08:17 | well the ambiguous wording in the update does not help.... | scepticalinvestor | |
11/8/2020 08:05 | SI - Market expectations are for FY revenue to be +36% so I doubt they are now forecasting a drop off in H2 | awesome45 | |
11/8/2020 08:05 | def buying opp now though. | scepticalinvestor | |
11/8/2020 07:37 | i think the FY statement comes across slightly negatively ie if they are 30% ahead in H1, the mkt provably wants to hear that they will be substantially ahead of previous guidance yoy.vis a vis H2 is expected to be substantially down yoy. | scepticalinvestor | |
11/8/2020 07:36 | I don't see it as a H2 forecast, but a statement that with the visibility they have at the moment they are already confident they will achieve market expectations for the full year, If H2 delivers further new orders we will see those expectations well beaten... It is rather confusingly worded though and that is why I think there will be a few selling, this however, allows some to buy at reduced prices. | troutisout | |
11/8/2020 07:34 | As Paul Hill suggests, given the excellent H1 performance IHC are imo simply being prudent in stating that they'll meet expectations. It's still pretty early in the financial year to confirm outperformance - I'd usually expect that later on in the accounting period. EDIT - sorry troutisout, our posts crossed, but similar sentiments :o)) | rivaldo | |
11/8/2020 07:32 | So we have an uplift of 30% for H1 revenues and the share price drops from it's lowly start. I wonder if people have been confused by the statement about being confident in achieving market expectations for the whole year. With a 30% uplift in H1, they are able at the start of H2 to say they expect to meet expectations for the whole year, with still over 5 months to go. Very positive as any new contracts/sales will add to the revenues for the year. | troutisout | |
11/8/2020 07:25 | hmm bit of a sell off.prob down to H2 forecast not being overly positive i assume | scepticalinvestor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions